ACE2 and COVID-19: SARS-CoV-2 infection induces oxidative stress and inflammation, leading to diminished GSH levels, which exacerbate severe COVID-19 outcomes and conditions like ARDS by triggering cytokine storms and disrupting the ACE/ACE2 equilibrium, ultimately resulting in respiratory failure.